Adial Pharmaceuticals, Inc. (ADIL) Financials

ADIL Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 29.1 million 28.9 million
March 31, 2026 5.2 million 1.5 million
Dec. 31, 2025 6.8 million 1.5 million
Sept. 30, 2025 5.7 million 1.2 million

ADIL Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -6.4 million 137100
March 31, 2026 -1.6 million 147900
Dec. 31, 2025 -1.3 million 168036
Sept. 30, 2025 -1.8 million 147334

ADIL Net Income

No data available :(

ADIL Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 28.7 million - -
March 31, 2026 4.6 million - -
Dec. 31, 2025 5.9 million - -
Sept. 30, 2025 4.6 million - -

ADIL Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 4.6 million
March 31, 2026 1.4 million
Dec. 31, 2025 1.1 million
Sept. 30, 2025 886852

ADIL Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 - 440000 5.4 million -
March 31, 2026 - 432530 1.6 million -
Dec. 31, 2025 4 619396 1.3 million -
Sept. 30, 2025 3 521069 1.2 million -

ADIL Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 - 46.2 million
March 31, 2026 - 141
Dec. 31, 2025 - 142
Sept. 30, 2025 - 141

ADIL

Price: $5.45

52 week price:
1.31
10.75

Earnings Per Share: -4.89 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 498900

Market Capitalization: 10.5 million

Links: